PubRank

Shu-Hsia Chen

Author PubWeight™ 55.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006 7.02
2 The terminology issue for myeloid-derived suppressor cells. Cancer Res 2007 4.37
3 The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res 2009 3.18
4 Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005 2.91
5 Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function. Blood 2007 2.65
6 Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008 2.05
7 Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2009 2.02
8 Role of immature myeloid Gr-1+ cells in the development of antitumor immunity. Cancer Res 2004 1.85
9 Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature 2012 1.75
10 Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 2010 1.75
11 Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011 1.72
12 Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 2013 1.57
13 Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest 2010 1.55
14 Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 2010 1.38
15 An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002 1.35
16 Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer 2009 1.28
17 Targeting immune suppressing myeloid-derived suppressor cells in oncology. Crit Rev Oncol Hematol 2010 1.25
18 NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation. Int J Cancer 2004 1.17
19 OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases. Mol Ther 2002 1.13
20 Polarization and reprogramming of myeloid-derived suppressor cells. J Mol Cell Biol 2013 1.12
21 DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity. Cell Biosci 2011 1.11
22 Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 2012 1.05
23 Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy. Cancer Res 2013 1.04
24 Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One 2012 0.95
25 Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation. J Immunol 2004 0.93
26 Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases: final report of a prospective clinical trial. Target Oncol 2013 0.91
27 Myeloid-derived suppressor cells: natural regulators for transplant tolerance. Hum Immunol 2010 0.91
28 In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery. Cancer Immunol Immunother 2003 0.85
29 IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach. Mol Ther 2003 0.84
30 R-Ras is required for murine dendritic cell maturation and CD4+ T-cell priming. Blood 2011 0.83
31 A functional recombinant human 4-1BB ligand for immune costimulatory therapy of cancer. J Immunother 2011 0.82
32 Advancements in immune tolerance. Adv Drug Deliv Rev 2007 0.82
33 Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy. J Cell Sci Ther 2011 0.79
34 Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic viruses. Oncoimmunology 2013 0.78
35 Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Hum Gene Ther 2002 0.77
36 Crucial effects of the anisotropy on optical field induced pattern formation in nematic liquid crystal films. Opt Express 2004 0.75
37 Relaxation of a field-unwound cholesteric liquid crystal. Phys Rev E Stat Nonlin Soft Matter Phys 2004 0.75